Swedbank’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-256,700
Closed -$3.95M 695
2025
Q4
$3.95M Hold
256,700
﹤0.01% 588
2025
Q3
$2.55M Hold
256,700
﹤0.01% 604
2025
Q2
$2.55M Hold
256,700
﹤0.01% 590
2025
Q1
$3.33M Hold
256,700
﹤0.01% 580
2024
Q4
$3.28M Hold
256,700
﹤0.01% 584
2024
Q3
$2.86M Hold
256,700
﹤0.01% 592
2024
Q2
$2.88M Sell
256,700
-44,700
-15% -$520K ﹤0.01% 583
2024
Q1
$3.74M Hold
301,400
0.03% 421
2023
Q4
$4.21M Hold
301,400
0.01% 537
2023
Q3
$4.45M Hold
301,400
0.01% 522
2023
Q2
$3.89M Hold
301,400
0.01% 546
2023
Q1
$2.96M Hold
301,400
0.01% 571
2022
Q4
$3.21M Hold
301,400
0.01% 547
2022
Q3
$3.15M Hold
301,400
0.01% 558
2022
Q2
$3.79M Buy
301,400
+256,700
+574% +$2.73M 0.01% 540
2022
Q1
$485K Buy
+44,700
New +$543K ﹤0.01% 720

Other funds holding DVAX

Swedbank's DVAX Position: Q1 2026 in Review

Swedbank sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 256,700 shares — an estimated $3.95M sold.

Swedbank first reported a position in DVAX in Q1 2022 and held it in 16 quarters. The position peaked at $4.45M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Swedbank reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Swedbank sold 256,700 Dynavax Technologies shares in Q1 2026, an estimated $3.95M.
  • Swedbank first reported a position in Dynavax Technologies in Q1 2022 and held it in 16 quarters.
  • Swedbank's Dynavax Technologies position peaked at $4.45M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Swedbank's 13F filing for Q1 2026, filed 29 Apr 2026.